Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY MHLW to Set Up New Study Group on Detailing Activities Report System for All Medical Institutions
January 6, 2020
-
REGULATORY JETRO’s New York Office Gets First Health and Welfare Head in 2 Years
January 1, 2020
-
TRENDS 51 Drugs Listed in 2019 with Total Peak Sales Forecast of 370 Billion Yen, Many for Orphan Diseases
December 27, 2019
-
REGULATORY Councilor Mori Urges Drug Maker Management to Straighten Up as He Bids Farewell to MHLW
December 27, 2019
-
TRENDS Top 10 PHARMA JAPAN Articles in 2019
December 26, 2019
-
REGULATORY Japan's Global Health Confab to Prepare New Grand Design for Regulatory Harmonization in Asia
December 26, 2019
-
BUSINESS Opdivo/Yervoy Combo Filed for Frontline NSCLC in Japan
December 26, 2019
-
BUSINESS Kyowa Hakko Bio Hit with 18-Day Biz Suspension over GMP Failings
December 25, 2019
-
BUSINESS 15% Share Eyed for Jointly Developed Symbicort Generics, Toa Set to Push Uptake with Support App
December 25, 2019
-
BUSINESS Towa to Acquire Spanish Generic Player, Set to Venture into US/European Markets
December 24, 2019
-
BUSINESS Daiichi Sankyo, AZ Nab US Nod for ADC Enhertu in Breast Cancer
December 24, 2019
-
REGULATORY Fumi Yamamoto 1st Woman to Become MHLW’s Top Pharmacy Officer
December 23, 2019
-
REGULATORY Japan Approves Keytruda’s 1st Line RCC, Head and Neck Cancer Use, Bavencio’s Label Expansion and More
December 23, 2019
-
REGULATORY Japan Panel Hammers Out FY2020 Drug Pricing Reform
December 20, 2019
-
BUSINESS Biogen Eyes 2020 Aducanumab Filing in Japan Too, Nailing Down Re-Dosing Study Details
December 19, 2019
-
REGULATORY FY2020 Drug Price Revision to Shed 110 Billion Yen in Central Govt Spending
December 18, 2019
-
REGULATORY Promotion Guidelines Now in Full Effect, MHLW Starts Survey to Capture Leading Examples of Company Set-Ups
December 17, 2019
-
REGULATORY Chuikyo Settles on “Third Price Revision” for Expansion of Comparator PMP Deduction Rule
December 16, 2019
-
BUSINESS Keytruda on Track to Become a US$10 Billion Drug in 2019
December 13, 2019
-
REGULATORY 6 Drugs Face Generic Entries, 2 Firms to Roll Out Symbicort Copies: December Listing
December 12, 2019
ページ
Japan’s FY2026 drug pricing reform will, for the first time, apply the “G1” price cut rule for long-listed original biologics…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…